Lyle Peter F SR

Director Lyle Peter F SR purchases 10,000 shares of HR at $17.21; holdings increase 60.3% to 26.6K shares.

Lyle Peter F SR, a director at Healthcare Realty Trust Inc, purchased 10,000 shares at $17.21, a price that sits 7.7% below the 52-week high of $18.78 and near the middle of the annual trading range. This transaction increased his shareholdings by 60.3%, from 16.6K to 26.6K shares, representing a material expansion of his position. His two prior purchases at this same ticker on 2024-08-30 and 2024-08-29 both generated positive 90-day returns (+4.2% and +5.4% respectively), establishing a pattern of well-timed accumulation at HR specifically. However, the company remains unprofitable with net income of $-93.0M in its most recent full fiscal year, even as revenue grew 44.1% year-over-year to $315.4M, creating a disconnect between top-line growth and near-term profitability that warrants attention to whether this buying pattern reflects conviction in a turnaround or exposure to execution risk.

Director Peter Lyle bought 1,500 shares at $17.71 avg; HR unprofitable but +44.1% annual revenue growth

Lyle Peter F SR, a director of Healthcare Realty Trust Inc, executed 2 separate purchases totaling 1,500 shares for $26,563.26 on consecutive days (August 29–30), increasing his holdings from 6,652 shares to 8,152 shares (+22.5%). The purchases occurred at a blended average price of $17.71, within the 52-week range of $12.94–$18.07 and near the current price of $17.94. The company reported a net loss of $-143,780,000.00 in its most recent full fiscal year, yet posted annual revenue growth of +44.1% (latest quarter revenue: $316,322,000.00). The director's multi-day accumulation at prices near the 52-week high occurs against a backdrop of unprofitability, suggesting the transaction requires examination of whether it reflects fundamental confidence or routine portfolio activity.